Informações:
Falhas:
ID
13579
Descrição
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00151242
Link
https://clinicaltrials.gov/show/NCT00151242
Palavras-chave
Versões (1)
- 17/02/2016 17/02/2016 -
Titular dos direitos
CC BY-NC 3.0
Transferido a
17 de fevereiro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Acute Myeloid Leukemia DRKS00003818 NCT00151242
Eligibility Acute Myeloid Leukemia NCT00151242
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukemia NCT00151242
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
AML
Item
newly diagnosed aml defined according to the world health organization (who)-classification (excluding acute promyelocytic leukemia [apl])
boolean
C0023467 (UMLS CUI [1])
Age
Item
ages 18-60 years
boolean
C0001779 (UMLS CUI [1])
written informed consent
Item
written informed consent of each patient at study entry.
boolean
C0021430 (UMLS CUI [1])
molecular and cytogenetical diagnostics
Item
molecular and cytogenetical diagnostics on initial bone marrow and peripheral blood specimen at the central reference laboratories
boolean
C2121080 (UMLS CUI [1])
C0010802 (UMLS CUI [2])
C0010802 (UMLS CUI [2])
bleeding
Item
bleeding independent of the aml
boolean
C0019080 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
C0023467 (UMLS CUI [2])
APL
Item
acute promyelocytic leukemia
boolean
C0023487 (UMLS CUI [1])
uncontrollable infection
Item
uncontrollable infection
boolean
C0009488 (UMLS CUI [1])
participation in a concurrent clinical study
Item
participation in a concurrent clinical study
boolean
C2348568 (UMLS CUI [1])
organ function
Item
insufficiency of the kidneys (creatinine > 1.5x upper normal serum level), of the liver (bilirubin, ast or ap > 2x upper normal serum level), severe obstructive or restrictive ventilation disorder, heart failure new york heart association (nyha) iii/iv
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C0035204 (UMLS CUI [5])
C1275491 (UMLS CUI [6])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C0035204 (UMLS CUI [5])
C1275491 (UMLS CUI [6])
severe neurological or psychiatric disorder interfering with ability to give an informed consent.
Item
severe neurological or psychiatric disorder interfering with ability to give an informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
no consent
Item
no consent for registration, storage and processing of the individual disease-characteristics and course.
boolean
C0021430 (UMLS CUI [1])
performance status who
Item
performance status who > 2
boolean
C1298650 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])